Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paroxetine hydrochloride hemihydrate, quantity: 22.2 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; calcium hydrogen phosphate dihydrate; sodium starch glycollate type a; magnesium stearate; calcium hydrogen phosphate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - for the treatment of:,? major depression and for the prevention of relapse of depressive symptoms;,? obsessive compulsive disorder and for the prevention of relapse of ocd;,? panic disorder and for the prevention of relapse of panic disorder;,? social anxiety disorder/social phobia; and,? generalised anxiety disorder;,? posttraumatic stress disorder.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - dosulepin (dothiepin) hydrochloride, quantity: 75 mg - tablet, film coated - excipient ingredients: povidone; maize starch; sodium starch glycollate; lactose monohydrate; purified talc; magnesium stearate; titanium dioxide; xanthan gum; polyvinyl alcohol; brilliant scarlet 4r; lecithin - the 75mg tablets are indicated only for the maintenance treatment of major depression. (see precautions).

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paroxetine hydrochloride, quantity: 22.22 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; microcrystalline cellulose; mannitol; basic butylated methacrylate copolymer; titanium dioxide; purified talc; polyvinyl alcohol; sodium lauryl sulfate; glyceryl monostearate - treatment of major depression and for the prevention of relapse of depressive symptoms; treatment of obsessive compulsive disorder and for the prevention of relapse of ocd; treatment of panic disorder and for the prevention of relapse of panic disorder; treatment of social anxiety disorder/ social phobia; treatment of generalised anxiety disorder; and treatment of post-traumatic stress disorder

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sertraline hydrochloride, quantity: 111.92 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; sodium starch glycollate type a; magnesium stearate; calcium hydrogen phosphate dihydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; peg-150 distearate; lauromacrogol 400 - children and adolescents sertraline hydrochloride is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd.,adults sertraline hydrochloride is indicated for: the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. sertraline hydrochloride is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. sertraline hydrochloride is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sertraline hydrochloride, quantity: 55.96 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; sodium starch glycollate type a; magnesium stearate; calcium hydrogen phosphate dihydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; peg-150 distearate; lauromacrogol 400 - children and adolescents sertraline hydrochloride is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd.,adults sertraline hydrochloride is indicated for: the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. sertraline hydrochloride is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. sertraline hydrochloride is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - paroxetine hydrochloride hemihydrate, quantity: 22.88 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; calcium hydrogen phosphate dihydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - aropax is indicated for treatment of major depression and for the prevention of relapse of depressive symptoms; obsessive compulsive disorder and for the prevention of relapse of ocd; panic disorder and for the prevention of relapse of panic disorder; social anxiety disorder/social phobia; generalised anxiety disorder; and posttraumatic stress disorder.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paroxetine hydrochloride, quantity: 22.22 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; microcrystalline cellulose; mannitol; basic butylated methacrylate copolymer; titanium dioxide; purified talc; polyvinyl alcohol; sodium lauryl sulfate; glyceryl monostearate - treatment of major depression and for the prevention of relapse of depressive symptoms; treatment of obsessive compulsive disorder and for the prevention of relapse of ocd; treatment of panic disorder and for the prevention of relapse of panic disorder; treatment of social anxiety disorder/ social phobia; treatment of generalised anxiety disorder; and treatment of post-traumatic stress disorder

Австралия - английский - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - sertraline hydrochloride, quantity: 112 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; calcium hydrogen phosphate; purified water; sodium starch glycollate type a; titanium dioxide; hypromellose; macrogol 8000; triacetin; polydextrose - children aged 6 years and older and adolescents with obsessive compulsive disorder (ocd): eleva is indicated for the treatment of children and adolescents with ocd. adults: eleva is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder, social phobia (social anxiety disorder) and the prevention of its relapse and treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - sertraline hydrochloride, quantity: 112 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; sodium starch glycollate type a; purified water; magnesium stearate; titanium dioxide; hypromellose; macrogol 8000; triacetin; polydextrose - children aged 6 years and older and adolescents with obsessive compulsive disorder (ocd): eleva is indicated for the treatment of children and adolescents with ocd. adults: eleva is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder, social phobia (social anxiety disorder) and the prevention of its relapse and treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - sertraline hydrochloride, quantity: 56 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: magnesium stearate; calcium hydrogen phosphate; sodium starch glycollate type a; purified water; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 8000; triacetin; polydextrose - children aged 6 years and older and adolescents with obsessive compulsive disorder (ocd): eleva is indicated for the treatment of children and adolescents with ocd. adults: eleva is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder, social phobia (social anxiety disorder) and the prevention of its relapse and treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.